ESR1 and breast cancer: In contrast, Saleh Gargari S. et al. reported the low expression of NNT-AS1 in breast cancer samples, and in subgroup analysis, the expression of NNT-AS1 in estrogen receptor (ER)-negative tumor samples was higher than ER-positive tumor samples [37].